Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Luciano Virdis"'
Autor:
Maria Teresa Ionta, Salvatore Ortu, Giuseppe Palmieri, Tito Sedda, Michela Barca, Panagiotis Paliogiannis, Giovanni Baldino, Annamaria Lanzillo, Giovanni Sanna, Luciano Virdis, Grazia Palomba, Mario Scartozzi, Mario Budroni, Antonio Pazzola, Francesca Capelli, Antonio Cossu
Publikováno v:
Oncology Letters 12 (2016): 1415–1421. doi:10.3892/ol.2016.4798
info:cnr-pdr/source/autori:Palomba G.; Cossu A.; Paliogiannis P.; Pazzola A.; Baldino G.; Scartozzi M.; Ionta M.T.; Ortu S.; Capelli F.; Lanzillo A.; Sedda T.; Sanna G.; Barca M.; Virdis L.; Budroni M.; Palmieri G./titolo:Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma/doi:10.3892%2Fol.2016.4798/rivista:Oncology Letters/anno:2016/pagina_da:1415/pagina_a:1421/intervallo_pagine:1415–1421/volume:12
Oncology Letters (2015).
info:cnr-pdr/source/autori:Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Budroni M, Palmieri G/titolo:Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma/doi:/rivista:Oncology Letters/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Palomba G.; Cossu A.; Paliogiannis P.; Pazzola A.; Baldino G.; Scartozzi M.; Ionta M.T.; Ortu S.; Capelli F.; Lanzillo A.; Sedda T.; Sanna G.; Barca M.; Virdis L.; Budroni M.; Palmieri G./titolo:Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma/doi:10.3892%2Fol.2016.4798/rivista:Oncology Letters/anno:2016/pagina_da:1415/pagina_a:1421/intervallo_pagine:1415–1421/volume:12
Oncology Letters (2015).
info:cnr-pdr/source/autori:Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Budroni M, Palmieri G/titolo:Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma/doi:/rivista:Oncology Letters/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
The presence of mutations in the KRAS gene is a predictor of a poor clinical response to EGFR-targeted agents in patients affected by colorectal cancer (CRC), but its significance as a global prognostic factor remains unclear. The aim of the present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::413952f196cf9723e3c42eebb3680c6b
https://doi.org/10.3892/ol.2016.4798
https://doi.org/10.3892/ol.2016.4798
Autor:
Giuseppina Sarobba, Giulia Gramignano, Antonella Manca, Milena Casula, Tito Sedda, Salvatore Ortu, Panagiotis Paliogiannis, Efisio Defraia, Giuseppe Palmieri, Francesca Capelli, Carlo Putzu, Maria Colombino, Luciano Virdis, Antonio Cossu, Mario Scartozzi, Francesco Tanda, Antonio Pazzola, Maria Teresa Ionta, Giovanni Sanna, Giovanni Baldino, Michela Barca, Annamaria Lanzillo, Grazia Palomba, Valentina Doneddu, Mario Budroni
Publikováno v:
Journal of Translational Medicine
Journal of translational medicine (Online) 14 (2016): 1–11. doi:10.1186/s12967-016-1053-z
info:cnr-pdr/source/autori:Palomba G.; Doneddu V.; Cossu A.; Paliogiannis P.; Manca A.; Casula M.; Colombino M.; Lanzillo A.; Defraia E.; Pazzola A.; Sanna G.; Putzu C.; Ortu S.; Scartozzi M.; Ionta M.T.; Baldino G.; Sarobba G.; Capelli F.; Sedda T.; Virdis L.; Barca M.; Gramignano G.; Budroni M.; Tanda F.; Palmieri G./titolo:Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study/doi:10.1186%2Fs12967-016-1053-z/rivista:Journal of translational medicine (Online)/anno:2016/pagina_da:1/pagina_a:11/intervallo_pagine:1–11/volume:14
Journal of translational medicine (Online) 14 (2016): 1–11. doi:10.1186/s12967-016-1053-z
info:cnr-pdr/source/autori:Palomba G.; Doneddu V.; Cossu A.; Paliogiannis P.; Manca A.; Casula M.; Colombino M.; Lanzillo A.; Defraia E.; Pazzola A.; Sanna G.; Putzu C.; Ortu S.; Scartozzi M.; Ionta M.T.; Baldino G.; Sarobba G.; Capelli F.; Sedda T.; Virdis L.; Barca M.; Gramignano G.; Budroni M.; Tanda F.; Palmieri G./titolo:Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study/doi:10.1186%2Fs12967-016-1053-z/rivista:Journal of translational medicine (Online)/anno:2016/pagina_da:1/pagina_a:11/intervallo_pagine:1–11/volume:14
Background Activation of oncogenes downstream the EGFR gene contributes to colorectal tumorigenesis and determines the sensitivity to anti-EGFR treatments. The aim of this study was to evaluate the prognostic value of KRAS, BRAF, NRAS and PIK3CA muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ea005c8e8b93b9379b7ca7475f26c7
https://pubmed.ncbi.nlm.nih.gov/27737711
https://pubmed.ncbi.nlm.nih.gov/27737711
Autor:
Grazia, Palomba, Antonio, Cossu, Panagiotis, Paliogiannis, Antonio, Pazzola, Giovanni, Baldino, Mario, Scartozzi, Maria Teresa, Ionta, Salvatore, Ortu, Francesca, Capelli, Annamaria, Lanzillo, Tito, Sedda, Giovanni, Sanna, Michela, Barca, Luciano, Virdis, Mario, Budroni, Giuseppe, Palmieri
Publikováno v:
Oncology Letters
The presence of mutations in the KRAS gene is a predictor of a poor clinical response to EGFR-targeted agents in patients affected by colorectal cancer (CRC), but its significance as a global prognostic factor remains unclear. The aim of the present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::98b0bb836bcd6a2f94b0c2d4f30c1b59
https://pubmed.ncbi.nlm.nih.gov/27446446
https://pubmed.ncbi.nlm.nih.gov/27446446